AstraZeneca to supply 400 million doses of COVID-19 Vaccine to Europe Ruchika Sharma15 Jun 2020 9:45 AM ISTAstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vaccine...
Serum Institute to infuse Rs 755 crore on potential COVID-19 vaccine Farhat Nasim10 Jun 2020 12:46 PM IST"Our manufacturing facility is ready and we plan to start production in two months. We are spending more than $100 million for this facility. Till the...
Potential Megamerger: AstraZeneca approaches Gilead about possible tie-up Hina Zahid8 Jun 2020 10:00 AM ISTAstraZeneca contacted Gilead last month about a possible tie-up, the people said, asking not to be identified because the details are private.
AstraZeneca signs licensing agreement with Serum Institute to supply 1 billion doses of COVID vaccine MD Bureau6 Jun 2020 6:13 PM ISTIn addition, it reached a $750 million agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) and the Vaccine Alliance called Gavi...
AstraZeneca, Daiichi Sankyo get Orphan Drug Designation for gastric cancer drug Enhertu Ruchika Sharma25 May 2020 11:56 AM ISTUS: Daiichi Sankyo Company Limited and AstraZeneca's Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the...
AstraZeneca secures orders for 400 million doses of COVID-19 vaccine Ruchika Sharma24 May 2020 11:15 AM ISTLondon: Drugmaker AstraZeneca secured its first agreements Thursday for 400 million doses of a COVID-19 vaccine, bolstered by an investment from the...
AstraZeneca receives 1 Billion USD investment for Oxford vaccine MD Bureau22 May 2020 10:45 AM ISTThe deal includes a Phase III clinical trial with 30,000 participants and a paediatric trial.
AstraZeneca, Daiichi Sankyo get USFDA Breakthrough Therapy status for lung cancer drug Enhertu Ruchika Sharma19 May 2020 12:32 PM ISTUK: AstraZeneca and Daiichi Sankyo Company, Limited has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of patients...
Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020 for emergency use Ruchika Sharma3 May 2020 12:00 PM ISTZurich/Geneva: Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany's BioNtech by the end of 2020 for...
AstraZeneca ink pact with Oxford University to develop, distribute COVID-19 vaccine ChAdOx1 nCoV-19 Ruchika Sharma3 May 2020 11:00 AM ISTUK: AstraZeneca and the University of Oxford have announced an agreement for the global development and distribution of the University's potential...
Glenmark Pharmaceuticals gets USFDA Tentative nod for Dapagliflozin, Saxagliptin Tablets Ruchika Sharma29 April 2020 4:14 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration for Dapagliflozin...
Positive results of phase III PROfound trial of Lynparza for metastatic castration-resistant prostate cancer: AstraZeneca, MSD Ruchika Sharma26 April 2020 9:00 AM ISTUS: AstraZeneca and MSD Inc. has announced further positive results from the Phase III PROfound trial of Lynparza (olaparib) in men with metastatic...
